Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 589.15B, Johnson & Johnson(JNJ) trades at $245.00. The stock has a price-to-earnings ratio of 22.15 and currently yields dividends of 2.1%.
On 2026-04-01, Johnson & Johnson(JNJ) stock traded between a low of $244.96 and a high of $245.00. Shares are currently priced at $245.00, which is +0.0% above the low and 0.0% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 7.66K, against a daily average of 8.19M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $141.50.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $141.50.
JNJ News
In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $180.54, changing hands for $181.62...
Key Points Johnson & Johnson has a stronger credit rating than the U.S. government. PepsiCo's brand loyalty gives it considerable pricing power. Walmart rank...
Johnson & Johnson (NYSE:JNJ) has entered a US$500 million R&D co-funding agreement with Royalty Pharma. The partnership is focused on advancing JNJ-4804, a fir...
Analyst ratings
59%
of 29 ratingsMore JNJ News
Key Points Johnson & Johnson is a Dividend King. The company's strong operations suggest regular payout increases aren't a thing of the past. 10 stocks we li...
IBD Stock Of The Day Why Johnson & Johnson Is Rebounding — Finally Licensing Johnson & Johnson Johnson & Johnson JNJ $ 243.60 $1.11 0.46% 32% IBD Stock Analysis...
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has...
Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss. By Rich Duprey Published Mar 31, 8:09AM EDT Quick Read Apple (AAPL), Microsof...
Oppenheimer raised the firm’s price target on Alumis to $55 from $50 and keeps an Outperform rating on the shares. The firm sees the three new orals for psorias...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Monte Rosa Therapeutics, Inc. recently reported a fourth-quarter 2025 net loss of US$46.14 million and entered a supply agreement with Johnson & Johnson to eval...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.